Author

H. Shah

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

The TROP2 targeting antibody-drug conjugate IMMU-132 enhances the efficacy of radiation therapy for lung cancer

The data suggests that the targeted delivery of IMMU-132 radiosensitizer at sub-therapeutic doses could broaden the therapeutic window of radiation therapy in lung cancer and may decrease the possibility of side effects.

H. Shah, S. Prem, R. Bose et al. · Cell Death & Disease · 0 citations